Inhibition of Non-histaminergic Pruritus Applied Using 3 Different Pruritogens
NCT04858360 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22
Last updated 2023-01-18
Summary
With this experiment, we want to use to investigate whether repeated application of EMLA cream as a tool to modulate non-histaminergic itching, which is produced using small needles from the plant mucuna pruriens (it is known that antihistamine does not attenuate this form of itch) and we want to compare the effect of short (1 hour) and prolonged (3 hours) application of EMLA. The sub-project takes place in 3 sessions over a period of 3 consecutive days (24 hours apart). All sessions will be identical.
Conditions
- Itch
Interventions
- DRUG
-
Emla 1 hour
At the start of each session, the middle forearms of the subject will each be divided into two squared areas (4x4 cm). On each arm, the two areas will be located 4 cm apart. Then one area will be pre-treated with cutaneous 2.5% lidocaine/2.5% prilocaine cream (EMLA cream) for 1 hour.
- DRUG
-
EMLA 3 hours
At the start of each session, the middle forearms of the subject will each be divided into two squared areas (4x4 cm). On each arm, the two areas will be located 4 cm apart. Then one area will be pre-treated with cutaneous 2.5% lidocaine/2.5% prilocaine cream (EMLA cream) for 3 hours.
- OTHER
-
Vehicle cream for 1 hour
At the start of each session, the middle forearms of the subject will each be divided into two squared areas (4x4 cm). On each arm, the two areas will be located 4 cm apart. Then two area will be pre-treated with a vehicle cream for 1 h.
- OTHER
-
Vehicle cream for 3 hours
At the start of each session, the middle forearms of the subject will each be divided into two squared areas (4x4 cm). On each arm, the two areas will be located 4 cm apart. Then two area will be pre-treated with a vehicle cream for 3 h.
- OTHER
-
Cowhage
Cowhage spicules are 1-2 mm in length and have a diameter of 1-3 μm. The spicules are inserted by gently rubbing 30-35 spicules into a 1 cm diameter skin area.
Sponsors & Collaborators
-
Aalborg University
lead OTHER
Principal Investigators
-
Silvia lo Vecchio · Aalborg University
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-11-15
- Primary Completion
- 2022-08-01
- Completion
- 2022-10-01
Countries
- Denmark
Study Locations
More Related Trials
-
EMLA Cream in Hysteroscopy Practice
NCT02640183 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparison of the Effects of Vapocoolant Spray and EMLA Cream on Pain During Needle Electromyography
NCT01606046 ·Status: COMPLETED ·Phase: PHASE4
-
Treating Tinnitus Using Eutectic Mixture of Local Anesthetics (EMLA) 5% Cream
NCT02266160 ·Status: COMPLETED ·Phase: PHASE4
-
EMLA Topical Anesthetic During Scaling and Root Planing
NCT01860235 ·Status: COMPLETED ·Phase: NA
-
Fractional Laser Assisted Topical Anesthesia
NCT02548533 ·Status: TERMINATED ·Phase: PHASE4
-
The Efficacy of EMLA Cream vs. Synera Patch for Pain Reduction During Venipuncture in Children
NCT00530803 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Topical Lidocaine to Decrease Discomfort With Intranasal Midazolam Administration
NCT02396537 ·Status: COMPLETED ·Phase: NA
-
Topical Analgesia Before Inhalational Anaesthesia
NCT04959409 ·Status: COMPLETED
-
Fractional Laser Assisted Delivery of Anesthetics
NCT02246179 ·Status: COMPLETED ·Phase: PHASE4
-
Battlefield Acupuncture for Acute/Subacute Back Pain in the Emergency Department
NCT03996564 ·Status: COMPLETED ·Phase: NA
-
EMLA and Sterile Water Injections - Pain From Injections
NCT02213185 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial of Cutaneous Xylocaine Spray to Reduce Intravenous Cannulation Pain in Adults
NCT02562144 ·Status: COMPLETED ·Phase: PHASE4
-
Study of ALGRX 3268 for Needlestick Pain in Children
NCT00132405 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Efficacy and Onset of Action of a Topical Anesthetic Marker
NCT07273916 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study of Safety and the Local Anesthetic Effect of AG-920 Ophthalmic Solution in a Pediatric Population
NCT05325853 ·Status: COMPLETED ·Phase: PHASE3
-
Topical Anesthetic for Procedures Through the Nose
NCT02667054 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of 5% Lidocaine Patch With Placebo Patch in Subjects With Herpes Zoster Associated Pain
NCT02452112 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Efficacy of Local Anesthetics to Reduce Shoulder Pain Post-Steroid Injections
NCT02592629 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy and Safety of ALGRX 3268 in Management of Needlestick Pain in Children.
NCT00140088 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Medical Clowns and Topical Anesthetic Cream on Pain and Anxiety in Children Undergoing Allergy Skin Tests
NCT01425619 ·Status: COMPLETED ·Phase: NA
-
A Safety and Effectiveness Pilot Study of PRF-108 and PRF-110 in Healthy Volunteers
NCT00883194 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy of Topical Lidocaine/Prilocaine in Pain Management in Pleurocentesis
NCT05984264 ·Status: UNKNOWN ·Phase: PHASE4
-
Experimental Pain Study to Assess Local Anesthetic Efficacy and Safety of CTY-5339 Anesthetic Spray in Normal Volunteers
NCT02908620 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Intravenous Lidocaine on Normal Sensation and Pain in Healthy Volunteers
NCT00657358 ·Status: COMPLETED ·Phase: NA
-
Pain Perception During Vulvar Biopsy
NCT03654417 ·Status: TERMINATED ·Phase: PHASE4